C07K 14/57563
Vasoactive intestinal peptide [vip]
Official title: {Vasoactive intestinal peptide [VIP]; Related peptides}
C07K14/57563 (Vasoactive intestinal peptide [vip]) appears on 279 US grants and 355 published applications in this corpus.
Search patents in C07K- Granted patents
- 279
- Published applications
- 355
- Assignees
- 176
- Inventors
- 702
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 8 | 0 |
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 7 | 0 |
| 2001 | 4 | 3 |
| 2002 | 2 | 5 |
| 2003 | 5 | 7 |
| 2004 | 8 | 13 |
| 2005 | 5 | 13 |
| 2006 | 10 | 18 |
| 2007 | 10 | 13 |
| 2008 | 9 | 22 |
| 2009 | 8 | 27 |
| 2010 | 6 | 16 |
| 2011 | 12 | 24 |
| 2012 | 12 | 18 |
| 2013 | 9 | 23 |
| 2014 | 11 | 17 |
| 2015 | 14 | 21 |
| 2016 | 16 | 21 |
| 2017 | 18 | 18 |
| 2018 | 9 | 8 |
| 2019 | 10 | 10 |
| 2020 | 10 | 12 |
| 2021 | 10 | 9 |
| 2022 | 4 | 11 |
| 2023 | 7 | 9 |
| 2024 | 8 | 9 |
| 2025 | 1 | 6 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Microorganism expressing vasoactive intestinal peptide, and use thereof9 Jun 2026US 12,649,771 B2Medytox Inc.
- Recombinant protein comprising multiple multi-peptide sets, pharmaceutical composition comprising the recombinant protein, and method for preparing the recombinant protein13 Jan 2026US 12,522,642 B2
- PACAP stabilized peptide20 May 2025US 12,304,932 B2Senju Pharmaceutical Co., Ltd.
- Methods of treatment with anti-PACAP antibodies10 Dec 2024US 12,162,936 B2H. Lundbeck A.S.
- Long-acting exendin-4 and use thereof3 Dec 2024US 12,157,761 B2Industry-Academic Cooperation Foundation Gyeongsang National University
- Novel brain disease therapeutic and use thereof6 Aug 2026US 2026/0226107 A1Avixgen Inc.
- Method for producing dual function proteins and its derivatives5 Feb 2026US 2026/0035429 A1Yuhan Corporation
- Effective truncated pacaps for disease modifying treatment of neurodegenerative diseases30 Oct 2025US 2025/0333465 A1Arizona Board of Regents on Behalf of the University of Arizona
- Stabilized pacap peptide21 Aug 2025US 2025/0263459 A1Senju Pharmaceutical Co., Ltd.
- Modified therapeutic agents and compositions thereof24 Jul 2025US 2025/0235508 A1The Scripps Research Institute
Most cited
By later US patents
- Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same397US 5,424,286 A1995
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Peptide agonists of GLP-1 activity176US 6,528,486 B1Zealand Pharma A/S · 2003
- Methods for regulating gastrointestinal motility138US 6,858,576 B1Amylin Pharmaceuticals, Inc. · 2005
- Use of exendins for the reduction of food intake124US 6,956,026 B2Amylin Pharmaceuticals, Inc. · 2005